Many of cannabinoids have therapeutic benefits and CBD is no exception. Benefits of CBD:
Scientists are rapidly discovering more and more about the rather amazing abilities of the cannabinoids found in the cannabis plant. Most of them have shown therapeutic value, as have the terpenes, which give the plant its distinct odors. There are over 125 terpenes and over 80 cannabinoids in cannabis and each strain has its own unique blend that creates its distinct effects.
CBD is just one cannabinoid. Cannabinoids are 21-carbon molecules that block or stimulate endocannabinoid receptors. It’s known that other cannabinoids, such as THC, THCV, CBN, and CBD, bind to CB1 and/or CB2 receptors, just as do the brain’s own naturally occurring cannabinoids – AEA and 2 AG.
Many of these cannabinoids have therapeutic value and CBD is no exception. It is a non-psychotropic cannabinoid, meaning it does not contribute to the euphoria associated with certain strains of cannabis. It is, however, psychoactive, because it crosses the blood-brain barrier. Unlike THC, CBD can be administered at relatively high doses without undesired psychological side effects.
CBD also has the effect of reducing the undesirable effects of high-THC cannabis, such as anxiety and paranoia, which allows a patient to ingest more THC, which has its own incredible medical effects. CBD is a powerful anti-epileptic, anti-depressant, anti-inflammatory, anti-nauseate, sleep aid, muscle relaxant, sedative and anti-proliferative.
What’s in A Name?
The federal government seems schizophrenic when it comes to CBD. Some interpret the government’s position to mean CBD is legal if it comes from hemp, despite hemp, cannabis and marijuana all being the exact same thing. We should not be surprised. An odd distinction existed from 1916 until 1942 where what you called the plant made the difference between cannabis being legal and marijuana being illegal.
Marijuana was illegal in most states but cannabis was not only legal in all states, but widely prescribed by physicians and available in over twenty-five over-the-counter medicines. The marijuana laws were more often applied to Hispanics and African Americans while Anglo-Caucasian and other pharmacy cannabis customers could obtain the medicinal cannabis with impunity.
The federal government has patented CBD. Here is what they say in their patent abstract:
Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidiol, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. A particular disclosed class of cananbinoids useful as neuroprotective antioxidants is formula (1) wherein the R group is independently selected from the group consisting of H, CH3 and COCH3.
The big selling point for the surging popularity of CBD has been that it is non-euphoric. The idea that using medication to feel good is not appropriate, unusual or unacceptable seems to almost uniquely apply to cannabis. Tranquilizers, antidepressants and ED medicines are all intended to make us feel emotionally better, even euphoric. While some may not want the euphoria associated with THC and other euphorogenic constituents of the plant, there is the therapeutic consideration of the benefit of using the whole plant (the entourage effect). As with any therapeutic agent, the physician will weigh the balance of the therapeutic effects of the side effects.
Many clinicians believe that using CBD as an isolated compound not only diminishes its therapeutic value but does not take full advantage of the medicinal value of cannabis. This is because of the entourage effect, the concept that the totality of the therapeutic constituents of the plant acting together are more effective than any single isolated compound acting alone.
The federal government promotes the concept that “Single-molecule pharmaceuticals are superior to ‘crude’ whole plant medicinals.” Here’s what Martin Lee, author of ‘Smoke Signals’ and ‘Acid Dreams’ had to say about this issue:
“According to the federal government, specific components of the marijuana plant (THC, CBD) have medical value, but the plant itself does not have medical value. Uncle Sam’s single-molecule blinders reflect a cultural and political bias that privileges Big Pharma products. Single-molecule medicine is the predominant corporate way, the FDA-approved way, but it’s not the only way, and it’s not necessarily the optimal way to benefit from cannabis therapeutics. Cannabis contains several hundred compounds, including various flavonoids, aromatic terpenes, and many minor cannabinoids in addition to THC and CBD. Each of these compounds has specific healing attributes, but when combined they create what scientists refer to as a holistic “entourage effect,” so that the therapeutic impact of the whole plant is greater than the sum of its single-molecule parts. The Food and Drug administration, however, isn’t in the business of approving plants as medicine. [See the scientific evidence].”